2026 Trends Shaping CNS Clinical Research Expert Insights

2026 Trends Shaping CNS Clinical Research

Clarity for Sponsors Building the Next Generation of CNS Therapies CNS clinical development continues to…

Morgan EdwardsFebruary 12, 2026

What Psychedelic Clinical Trials Need Now: Key Takeaways from the Bold Conversation Expert Insights

What Psychedelic Clinical Trials Need Now: Key Takeaways from the Bold Conversation

Psychedelic drug development is accelerating, yet many of the core structures that support rigorous, interpretable…

cogres1January 8, 2026

Pledge to Be Bold: A Collective Movement for Progress in CNS Clinical Research Inside CRC

Pledge to Be Bold: A Collective Movement for Progress in CNS Clinical Research

Bold research is more than a phrase at CRC. It reflects the mindset required to…

cogres1January 8, 2026

Purpose in Practice: World Mental Health Day 2025 Inside CRC

Purpose in Practice: World Mental Health Day 2025

Each year, World Mental Health Day calls attention to the need for greater understanding, access,…

cogres1January 8, 2026

Alzheimer’s Stories at the Heart of Our Why Inside CRC

Alzheimer’s Stories at the Heart of Our Why

September is World Alzheimer’s Month, an international campaign to raise dementia awareness and challenge stigma.…

cogres1January 8, 2026

Speed Kills: Is Your Neuropsychiatric Trial at Risk? Expert Insights

Speed Kills: Is Your Neuropsychiatric Trial at Risk?

Why do so many neuropsychiatric trials fail? It is a question that sponsors, investigators, and…

cogres1January 8, 2026

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer Breaking News

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer

ST. PETERSBURG, Fla., Sept. 2, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a leading full-service…

cogres1January 8, 2026

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories Expert Insights

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories

Psychedelic medicine has re-emerged as one of the most exciting frontiers in psychiatric and psychological…

cogres1January 8, 2026

CRC Becomes Accredited Medidata Rave® EDC Partner Breaking News

CRC Becomes Accredited Medidata Rave® EDC Partner

ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO…

cogres1January 8, 2026

Mastering Agitation Endpoints with Assessment Expertise Collaboration Success Stories

Mastering Agitation Endpoints with Assessment Expertise

Consistent, high-quality assessments are essential in agitation trials. In this focused case study, see how…

cogres1January 8, 2026

Seamless Execution Across Early-Phase Alzheimer’s Trials Collaboration Success Stories

Seamless Execution Across Early-Phase Alzheimer’s Trials

In the face of pandemic-era recruitment barriers and aggressive timelines, CRC partnered with a sponsor…

cogres1January 8, 2026

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research Expert Insights

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research

(GLP-1 RAs), initially developed for the treatment of type 2 diabetes, have rapidly become a…

cogres1January 8, 2026